Jonathan Wilkins, marketing director of obsolete industrial parts supplier EU Automation, explains how biopharmaceutical plants can benefit from automation.
Phil Morton, chief technical officer, Albumedix discusses the effects that albumin can infer on APIs in formulations, and the proposed mechanism behind them.
At this year's Pharmapack, Reece Armstrong caught up with event director Silvia Forroova to discuss why the show has grown so much and what to expect from the industry in 2019.
Reece Armstrong sits down with Dr Paul Peter Tak, venture partner at Flagship Pioneering and the former senior vice president of R&D, development leader and chief immunology officer at GSK to gain a global perspective on Brexit and pharma.
Heather Oebel, NPI enterprise solutions manager at Winshuttle examines the changing drug landscape and why pharmaceutical companies need to go digital with their data.
Nick Beckett, managing partner and co-head of CMS Life Sciences & Healthcare Group writes about China’s approach to attracting global pharmaceutical and digital health companies.
Senior professional support lawyer Paul England and Matthew Royle, partner in the life sciences team at international law firm Taylor Wessing discuss what the introduction of a manufacturing waiver to the SPC legislation means for manufacturers.
Martin Gadsby, director at Optimal Industrial Technologies, looks at how Process Analytical Technology (PAT) can speed up the development and production of new and existing drugs.
